Healthcare Success

  Growth in this market can be attributed to factors such as growing need to curtail healthcare costs, focus on patient-centric care delivery, growing adoption of EHRs and other HCIT solutions, government initiatives for enhancing patient care and safety, government funding for healthcare interoperability.   The global health information exchange market is expected to reach 2.0 billion by 2025 from an estimated USD 1.1 billion in 2020 at a CAGR of 12.2% during the forecast period. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249987292   Market Segmentation: Based on the type, the health information exchange market is segmented into directed(push HIE), query-based (pull-HIE), consumer-mediated exchange solutions. The directed (push HIE) exchange segment is expected to account for the largest share of the market in 2020. The large share of this segment can primarily be attributed to advantages like directed exchange prevents redu...

  The global non-invasive prenatal testing market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market. To know about the assumptions considered for the study download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690 North America dominated the market, followed by Europe. The large share of this market can primarily be attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region. Growth in the North American market is supported by the presence of a better reimbursement s...

The blood glucose monitoring systems market is well established owing to the dominance by prominent market players. In 2016, Roche (Switzerland), Abbott (US), LifeScan (US), and Ascensia (Switzerland) held a share of approximately 65% to 70% of the self-monitoring blood glucose systems market whereas, Medtronic (Ireland), Dexcom (US) and Abbott (US) held a share of approximately 95% to 100% of continuous glucose monitoring systems market. Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14912252   The global blood glucose monitoring systems market is projected to reach USD 10.58 Billion by 2022 from an estimated USD 8.35 Billion in 2017 at a CAGR of 4.8%.  North America would continue to be the largest market for power system simulators followed by Asia Pacific during the forecast period. The global market is dominated by major players including ABB (Switzerland), Schneider Electric (France), Siemens (Germany), GE (US), ETAP (US), RTDS Tech...

  The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. Request for Sample PDF @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145 The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan). The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. F. Hoffmann-La Roche AG (Switzerland) the leading player in the anatomic pathology market in 2020. The company has a wide range of products in the consumables segment...

  Growth in the cryotherapy market is primarily driven by factors such as the growing incidences of sports injuries, cardiac diseases, & cancers, and technological advancements in cryotherapy technology. The rising incidence of sports injuries, cardiac conditions, and cancers and the growing demand for minimally invasive procedures are the key drivers of the cryotherapy market. Technological advancements in cryotherapy equipment and its growing popularity in the beauty, wellness, and fitness industries are also supporting the growth of this market.   Global Forecast to 2024", is expected to reach USD 319 million by 2024 from USD 206 million in 2019, at a CAGR of 9.1%.   Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=33280524   Cryotherapy Market Dynamics   Driver: Technological Advancements in cryotherapy equipment   Cryotherapy has become an important treatment option, mainly due to the various technologic...